HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA [NA]
This clinical trial investigates telemedicine-delivered Common Elements Treatment Approach (CETA) to reduce unhealthy alcohol use in people …
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: A Setting Focus Overdose Prevention Intervention [NA]
A Johns Hopkins trial on a setting-focused overdose prevention intervention is currently recruiting participants among people with HIV infec…
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: The Role of Probiotics in HIV Patients With Immunological Non-Responder [Phase 2]
A Phase 2 trial evaluating probiotics in HIV patients who are immunological non-responders has completed and posted results.
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV [Phase 2]
A Phase 2 clinical trial evaluating humoral and cellular immune responses to the Gardasil HPV vaccine in people with and without HIV, curren…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Harnessing Male Peer Networks to Enhance Engagement With HIV Prevention [NA]
A university-sponsored HIV prevention study is currently recruiting to test how male peer networks can improve engagement with HIV preventio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Pre-exposure Prophylaxis (PrEP) for Health [NA]
A Brown University–led clinical trial is currently recruiting to evaluate pre-exposure prophylaxis (PrEP) for HIV prevention in individuals …
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: An Adaptive Randomized Controlled Trial [NA]
Columbia University sponsors an adaptive randomized controlled trial protocol that is currently recruiting. The study targets multidrug-resi…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV [NA]
This document outlines an ongoing clinical trial evaluating high-intensity exercise to improve functional limitations and exercise habits in…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Screen Smart: Using Digital Health to Improve HIV Screening and Prevention [NA]
This clinical trial update shows that the Screen Smart digital health program to improve HIV screening and prevention is currently recruitin…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection [Phase 2]
Phase 2 pilot study evaluating the safety, tolerability, and antiretroviral activity of dasatinib in adults with recent HIV-1 infection. The…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test [NA]
This is a clinical trial update about validating self-testing using the INSTI Multiplex HIV1/2 and Syphilis antibody test; the study is curr…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST) [Phase 1]
Phase 1 clinical trial update evaluating donor-derived HIV-specific T-cells to assess safety, immune responses, and virologic effects in HIV…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults [Phase 1]
This clinical trial update covers a Phase 1 study of the bispecific antibody 10E8.4/iMab and the VRC07-523LS monoclonal antibody in HIV-1-in…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: A Gender Transformative Implementation Strategy With Providers to Improve HIV Outcomes in Uganda [NA]
The document reports a completed clinical trial in Uganda evaluating a gender-transformative implementation strategy with providers to impro…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE [Phase 3]
Phase 3 LATITUDE study reports results for a long-acting HIV therapy intended to improve daily treatment success; results were posted on 202…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Addressing Violence and HIV Care Among Transgender Women [NA]
The University of Michigan–sponsored study on violence and HIV care among transgender women has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing [NA]
This clinical trial update describes a study using predictive analytics and clinical decision support to improve prescribing of PrEP for HIV…
-
FDA approval · 2025-04-22FDA Approved: FOSAMPRENAVIR CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for fosamprenavir calcium from Sun Pharmaceutical Industries, Inc., updating the approval under the …
-
CLINICAL_TRIALS withdrawal · 2025-04-22Clinical Trial Update: VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI) [Phase 1]
Phase 1 MAD study of VH3739937 in healthy volunteers has been withdrawn, including assessments of relative bioavailability, food effect, and…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings [NA]
Clinical trial update for a group-based intervention to improve mental health and adherence among youth living with HIV in low-resource sett…
-
FDA approval · 2025-04-21FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM) [Phase 2]
Phase 2 study evaluating naltrexone to reduce heavy alcohol use among men who have sex with men, including participants with HIV; results we…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study [NA]
Clinical trial update documenting an Analytical Treatment Interruption (ATI) to assess whether the immune system can control HIV in particip…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Accelerated ART Initiation for PWHIV Who Are Out of Care [Phase 4]
Phase 4 trial update on accelerated initiation of antiretroviral therapy for people with HIV who are out of care; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART [Phase 2]
A Phase 2 trial evaluated early administration of Romidepsin and the HIV broadly neutralizing antibody 3BNC117 in treatment-naïve patients s…